VentureMed Group Receives European Medical Device Regulation (MDR) Certification for FLEX Vessel Prep™ System
Il sito "il Centro Tirreno.it" utilizza cookie tecnici o assimiliati e cookie di profilazione di terze parti in forma aggregata a scopi pubblicitari e per rendere più agevole la navigazione, garantire la fruizione dei servizi, se vuoi saperne di più leggi l'informativa estesa, se decidi di continuare la navigazione consideriamo che accetti il loro uso.
Informativa estesa
07
Lun, Set

Abbiamo 4977 visitatori e nessun utente online

VentureMed Group Receives European Medical Device Regulation (MDR) Certification for FLEX Vessel Prep™ System

Immediapress
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

(Adnkronos) - MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company is an early recipient of MDR

certification. Gaining MDR certification ensures the FLEX device is in alignment with described requirements and conformity assessment procedures that must be met before medical devices are introduced into the European Economic Area.  

"CE Mark under these new requirements is more stringent than the CE Mark under the Medical Device Directive and is focused on quality as well as patient safety. This significant achievement is a testament to our company's dedication to provide the safest and highest quality products for our customers and their patients," commented Jill Schweiger, VentureMed's VP of Clinical, Regulatory, and Quality. 

"MDR certification demonstrates our commitment to quality and will enable continued commercial expansion of the FLEX Vessel Prep System into the CE marked geographies." said Denis Harrington, VentureMed's President and CEO.  

About VentureMed Group, Inc. and the FLEX Vessel Prep System 

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of stenoses of AV fistulas and grafts and PAD. The FLEX VP™ System is a unique, non-balloon-based approach to optimizing revascularization. FLEX creates controlled-depth micro-incisions, releasing circumferential tension that may lead to improved vessel compliance, enabling luminal gain at lower pressure and with less vessel trauma, which may help limit restenosis. FLEX was designed to provide controlled and predictable pre-treatment to optimize outcomes in complex stenoses & lesions of any length or vessel morphology. The FLEX VP System received CE Mark and 510(k) clearance from the US Food and Drug Administration. 

For more information, visit www.VentureMedgroup.com. 

Media contact: Kathy Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.(763-296-2026) 

Logo - https://mma.prnewswire.com/media/658751/4255490/VentureMed_Group_Logo.jpg  

  

View original content:https://www.prnewswire.co.uk/news-releases/venturemed-group-receives-european-medical-device-regulation-mdr-certification-for-flex-vessel-prep-system-301919115.html  

 

Author: RedWebsite: http://ilcentrotirreno.it/Email: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.